{"id":70770,"date":"2026-05-12T10:58:38","date_gmt":"2026-05-12T10:58:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70770"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"hgh-191aa","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/hgh-191aa\/","title":{"rendered":"HGH 191AA"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 HGH 191AA?<\/h3>\n<p style=\"margin: 0;\"><strong>HGH 191AA<\/strong> is recombinant human growth hormone in its full 191-amino-acid native sequence form (somatropin), a 22-kDa pituitary peptide hormone produced by recombinant DNA technology to exactly match the endogenous human GH polypeptide. It acts directly on the growth hormone receptor (GHR) to activate JAK2\/STAT5 signalling and drive hepatic IGF-1 production. This is the modern pharmaceutical-quality form (191AA) as opposed to the obsolete bacterial 192AA recombinant variant. Supplied in 10\u201340\u00a0IU lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">12629-01-5 (somatropina) \/ 96827-07-5 (somatropina recombinante)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Tipo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Prote\u00edna recombinante \u2014 sequ\u00eancia nativa de 191 amino\u00e1cidos da hormona de crescimento humano (somatropina); INN: somatropina<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">22.124 Da (~22 kDa)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Estrutura<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cadeia polipept\u00eddica \u00fanica de 191 amino\u00e1cidos dobrada numa topologia can\u00f3nica de feixe de quatro h\u00e9lices, estabilizada por duas liga\u00e7\u00f5es dissulfureto intramoleculares (Cys53\u2013Cys165 e Cys182\u2013Cys189). A designa\u00e7\u00e3o 191AA distingue a forma farmac\u00eautica moderna de qualidade da variante bacteriana-recombinante obsoleta de 192AA que transportava um amino\u00e1cido extra de metionina N-terminal.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Atividade Unit\u00e1ria<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Aproximadamente 3 UI por mg de HGH recombinante 191AA (unidades internacionais, padr\u00e3o da OMS)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Prote\u00edna recombinante liofilizada (p\u00f3 branco a branco-acinzentado)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226598% (verificado por HPLC, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar dentro de ~14 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 as prote\u00ednas recombinantes s\u00e3o particularmente sens\u00edveis \u00e0 desnatura\u00e7\u00e3o por congela\u00e7\u00e3o-descongela\u00e7\u00e3o.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada). Prote\u00edna transportadora (BSA, 0,1%) opcional para dilui\u00e7\u00f5es de trabalho para minimizar perdas por adsor\u00e7\u00e3o.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 HGH 191AA?<\/h2>\n<p><strong>HGH 191AA<\/strong> is recombinant human growth hormone (somatropin) in the 191-amino-acid native human sequence form. It is produced by recombinant DNA technology and matches the endogenous human GH polypeptide exactly \u2014 same 191 amino acids, same four-helix bundle three-dimensional structure, same two intramolecular disulfide bonds at Cys53\u2013Cys165 and Cys182\u2013Cys189. The 191AA designation specifically distinguishes the modern pharmaceutical-quality recombinant form from the older 192AA variant produced in bacterial expression systems, which carried an additional N-terminal methionine that introduced minor antigenicity differences and has been largely phased out of studies and clinical use. HGH is the principal peptide hormone secreted by somatotroph cells of the anterior pituitary in episodic pulses, with peak amplitudes occurring during early slow-wave sleep and following intense exercise. Endogenous secretion is regulated upstream by hypothalamic GHRH (positive) and somatostatin (negative). The recombinant 191AA form has empirical molecular weight 22,124\u00a0Da, INN somatropin, CAS number 12629-01-5 for the native protein and 96827-07-5 for the recombinant form. Standard unit activity for recombinant 191AA HGH is approximately 3\u00a0IU per mg according to the WHO International Standard. The compound is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. HGH is the most stringently regulated of all peptides in many jurisdictions and is approved for specific medical indications (paediatric GH deficiency, adult GH deficiency, Turner syndrome, idiopathic short stature, AIDS wasting, short bowel syndrome) only under prescription. For peptides that stimulate endogenous GH release rather than supplying exogenous GH, see our <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> p\u00e1ginas de produtos. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Sinaliza\u00e7\u00e3o do Recetor da Hormona do Crescimento e o Eixo GH\/IGF<\/h2>\n<p>What makes HGH 191AA mechanistically distinctive among peptides is that it is the <strong>ligando ex\u00f3geno direto<\/strong> for the growth hormone receptor \u2014 not an analog, not a secretagogue, but the native polypeptide itself. The downstream signalling cascade has been characterised across decades of published studies:<\/p>\n<ul>\n<li><strong>Liga\u00e7\u00e3o ao recetor da hormona do crescimento (GHR) e homodimeriza\u00e7\u00e3o<\/strong> \u2014 O HGH liga-se a uma \u00fanica mol\u00e9cula de GHR com alta afinidade e induz a homodimeriza\u00e7\u00e3o com uma segunda unidade recetora, formando o complexo ligando-recetor bioativo 1:2. O recetor dimerizado recruta a Janus quinase 2 (JAK2) citoplasm\u00e1tica para o motivo da caixa recetora intracelular, levando \u00e0 trans-fosforila\u00e7\u00e3o da JAK2 e do pr\u00f3prio recetor. Este \u00e9 o mecanismo can\u00f3nico de ativa\u00e7\u00e3o do recetor de citocinas Tipo I.<\/li>\n<li><strong>Ativa\u00e7\u00e3o do fator de transcri\u00e7\u00e3o JAK2\/STAT5<\/strong> \u2014 A JAK2 fosforilada fosforila o Transdutor de Sinal e Ativador da Transcri\u00e7\u00e3o 5 (STAT5), principalmente o STAT5b, que depois dimeriza e transloca para o n\u00facleo, onde se liga aos promotores de genes responsivos \u00e0 GH. O principal resultado transcricional \u00e9 a indu\u00e7\u00e3o da express\u00e3o de IGF-1 (Fator de Crescimento Insul\u00ednico 1) nos hepat\u00f3citos \u2014 o principal efeito end\u00f3crino perif\u00e9rico promotor do crescimento da GH. Outros genes responsivos \u00e0 GH incluem prote\u00ednas SOCS (feedback negativo), CIS e um programa de genes de s\u00edntese proteica hep\u00e1tica.<\/li>\n<li><strong>Efeitos teciduais diretos e indiretos (mediados por IGF-1)<\/strong> \u2014 A GH tem dois modos principais de a\u00e7\u00e3o. <em>Efeitos diretos<\/em>: lipolysis at adipocytes, glucose-counter-regulatory effects opposing insulin in muscle and liver, and direct anabolic signalling at GHR-expressing tissues including chondrocytes (in long-bone growth-plate studies) and immune cells. <em>Efeitos indiretos via IGF-1<\/em>: hepatic IGF-1 acts at the IGF-1 receptor on essentially every cell type to drive Akt\/mTOR-mediated protein synthesis, cell proliferation, and survival signalling. The compound <a href=\"https:\/\/medsbase.com\/pt-pt\/igf-1-lr3\/\">IGF-1 LR3<\/a> \u00e9 a ferramenta can\u00f3nica do recetor direto de IGF utilizada para dissecar os efeitos diretos da GH dos efeitos a jusante mediados por IGF-1.<\/li>\n<\/ul>\n<p>HGH has a relatively short plasma half-life (~3\u20135 hours following subcutaneous administration of the native protein) due to renal filtration and proteolytic clearance. The pulsatile pattern of endogenous secretion is a defining feature of the GH axis \u2014 tonic continuous exposure to GH produces different downstream gene-expression patterns than pulsatile exposure, an important consideration in protocol design. Subcutaneous administration is the standard administration route. For endogenous-pulse-pattern studies, secretagogues like <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> preservam a assinatura puls\u00e1til natural; para farmacologia direta do recetor da GH, a HGH ex\u00f3gena fornece o est\u00edmulo mais limpo. <\/p>\n<h2>Published Evidence<\/h2>\n<p>HGH 191AA is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacologia do eixo da hormona de crescimento<\/strong> \u2014 direct GHR signalling, JAK2\/STAT5 phosphorylation kinetics, downstream IGF-1 induction; canonical peptide for the GH side of the GH\/IGF-1 axis<\/li>\n<li><strong>IGF-1 induction studies<\/strong> \u2014 express\u00e3o g\u00e9nica de IGF-1 hep\u00e1tica, din\u00e2mica de IGF-1 circulante, regula\u00e7\u00e3o de prote\u00ednas de liga\u00e7\u00e3o a IGF (IGFBP); comparador para <a href=\"https:\/\/medsbase.com\/pt-pt\/igf-1-lr3\/\">IGF-1 LR3<\/a>-based studies that bypasses the GH step<\/li>\n<li><strong>Anabolic signalling studies<\/strong> \u2014 s\u00edntese proteica do m\u00fasculo esquel\u00e9tico via Akt\/mTOR (largamente mediada por IGF-1), sinaliza\u00e7\u00e3o de condr\u00f3citos da placa de crescimento \u00f3sseo, lip\u00f3lise do tecido adiposo<\/li>\n<li><strong>Hepatic metabolism studies<\/strong> \u2014 produ\u00e7\u00e3o hep\u00e1tica de glucose, metabolismo lip\u00eddico, resposta transcricional espec\u00edfica de hepat\u00f3citos \u00e0 estimula\u00e7\u00e3o com GH<\/li>\n<li><strong>Modelos pr\u00e9-cl\u00ednicos de defici\u00eancia de GH<\/strong> \u2014 estudos de resgate em roedores hipofisectomizados, modelos de ratos an\u00f5es Snell e Ames, caracteriza\u00e7\u00e3o de ratos transg\u00e9nicos com knockout do GHR<\/li>\n<li><strong>Sleep and circadian rhythm support<\/strong> \u2014 rela\u00e7\u00e3o entre a arquitetura do sono e a secre\u00e7\u00e3o puls\u00e1til de GH, depend\u00eancia do GH no sono de ondas lentas<\/li>\n<li><strong>Comparative GH-axis studies<\/strong> \u2014 compara\u00e7\u00e3o com an\u00e1logos de GHRH (\"<a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295<\/a>) e secretagogos da hormona de crescimento (<a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-6\/\">GHRP-6<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-2\/\">GHRP-2<\/a>) que produzem pulsos end\u00f3genos de GH em vez de substitui\u00e7\u00e3o ex\u00f3gena de GH<\/li>\n<li><strong>Tissue regeneration and wound healing studies<\/strong> \u2014 literatura publicada sobre os efeitos da GH em modelos de les\u00f5es por queimaduras, recupera\u00e7\u00e3o cir\u00fargica e regenera\u00e7\u00e3o de tecidos; rela\u00e7\u00e3o com <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> healing peptide studies<\/li>\n<li><strong>Endocrinology and aging studies<\/strong> \u2014 somatopause and age-related GH decline, comparative studies of GH replacement vs GH-axis stimulation in aging study models.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre onde o HGH 191AA se enquadra no panorama dos pept\u00eddeos do eixo de crescimento, consulte <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> como comparadores do eixo GHRH, <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> como comparador seletivo de GHS, e <a href=\"https:\/\/medsbase.com\/pt-pt\/igf-1-lr3\/\">IGF-1 LR3<\/a> como agonista do recetor IGF a jusante. Navegue pelo <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>MedsBase stocks HGH 191AA in five lyophilized vial sizes calibrated by international units (IU). Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentra\u00e7\u00e3o do Frasco (IU)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Massa Aproximada<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0IU<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3.3\u00a0mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dosagem piloto, titula\u00e7\u00e3o de n\u00edvel baixo, protocolos de ciclo curto<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>15\u00a0IU<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~5\u00a0mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, mid-titration arm<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>24\u00a0IU<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~8\u00a0mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle studies, higher-dose titration arm<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>36\u00a0IU<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~12\u00a0mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos de v\u00e1rias semanas a partir de um \u00fanico frasco, volume de reconstitui\u00e7\u00e3o menor por dose<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>40\u00a0IU<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~13.3\u00a0mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Bulk packs vial, lowest per-IU cost, multi-cohort studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All five strengths are the same chemical form (lyophilized recombinant 191AA somatropin, \u226598% HPLC purity). The IU labelling convention is the standard for HGH studies and clinical literature; the approximate mg equivalents are provided for users calibrating dose against mg-based literature. Higher-IU vials require smaller reconstitution volumes per unit dose, useful for minimising injection volume in rodent protocols or running extended-cycle studies from a single vial. <\/p>\n<h2>Como Comparar \u2014 HGH 191AA vs Sermorelina<\/h2>\n<p>HGH 191AA e <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> represent the two opposing pharmacological approaches to GH-axis studies: exogenous GH replacement vs endogenous GH stimulation. The comparison is one of the most-cited in growth-axis studies design because the two approaches answer different studies questions and produce qualitatively different downstream phenotypes. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">HGH 191AA<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Sermorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>O que \u00e9<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GH ex\u00f3geno em si (recombinante)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">An\u00e1logo de GHRH(1-29) \u2014 estimula o GH end\u00f3geno<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">191 amino\u00e1cidos (~22 kDa)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">29 amino\u00e1cidos (~3 kDa)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Modo de a\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agonismo direto do GHR (substitui\u00e7\u00e3o)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agonismo do recetor de GHRH hipotal\u00e2mico (estimula\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Padr\u00e3o de pulso de GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Exposi\u00e7\u00e3o t\u00f3nica ap\u00f3s cada inje\u00e7\u00e3o<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Puls\u00e1til (preserva o ritmo natural)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Retroa\u00e7\u00e3o negativa<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ignorada (suprime os somatotrofos end\u00f3genos)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Preservada (a somatostatina ainda est\u00e1 ativa)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3\u20135 horas (SC)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~10\u201320 minutos (muito curto)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico aprovado<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">M\u00faltiplas indica\u00e7\u00f5es aprovadas (Genotropin, Humatrope, Norditropin, etc.)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aprova\u00e7\u00e3o hist\u00f3rica da FDA para GHD pedi\u00e1trico (Geref); descontinuado<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20138 UI por administra\u00e7\u00e3o<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500\u00a0mcg por administra\u00e7\u00e3o<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies interested in direct GHR pharmacology, IGF-1 induction kinetics, or replacing GH in deficiency models, HGH 191AA is the canonical tool because it provides the exogenous ligand directly. For studies interested in physiological pulsatile GH dynamics, hypothalamic-pituitary-axis pharmacology, or any protocol where preserving the natural somatostatin feedback loop matters, <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> (e o relacionado <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a>) provide the upstream-stimulation alternative. Many published studies designs use both in parallel arms to dissect direct GH effects from secretagogue-stimulated endogenous GH effects. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138\u00a0\u00b0C na embalagem original para estoque de trabalho de curto prazo. Para armazenamento de longo prazo n\u00e3o aberto, congele a \u221220\u00a0\u00b0C. O HGH recombinante liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220\u00a0\u00b0C por at\u00e9 36 meses. O estado de dobragem de quatro h\u00e9lices \u00e9 preservado na forma liofilizada. Evite ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3 liofilizado. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injete \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o bolo liofilizado). Os volumes de reconstitui\u00e7\u00e3o recomendados variam conforme a for\u00e7a do frasco \u2014 para um frasco de 10\u00a0UI, 1,0\u00a0mL de \u00e1gua bacteriost\u00e1tica produz uma concentra\u00e7\u00e3o de trabalho de 10\u00a0UI\/mL; para um frasco de 36\u00a0UI, 1,5\u00a0mL produz 24\u00a0UI\/mL. Agite suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> agite \u2014 e permita 5\u201310 minutos para dissolu\u00e7\u00e3o completa. As prote\u00ednas recombinantes dissolvem-se mais lentamente do que os pequenos p\u00e9ptidos; n\u00e3o apresse o passo de dissolu\u00e7\u00e3o. Agita\u00e7\u00e3o vigorosa pode perturbar a estrutura de quatro h\u00e9lices e reduzir a atividade. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve ser clara e incolor, sem part\u00edculas vis\u00edveis. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138\u00a0\u00b0C e use dentro de 14 dias para estabilidade ideal \u2014 um pouco menos do que a janela de 30 dias para p\u00e9ptidos sint\u00e9ticos menores porque a prote\u00edna maior de quatro h\u00e9lices \u00e9 mais suscet\u00edvel a perdas por adsor\u00e7\u00e3o superficial e desamida\u00e7\u00e3o lenta. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o produzem agrega\u00e7\u00e3o e perda de atividade biol\u00f3gica. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. Para dilui\u00e7\u00f5es de trabalho prolongadas abaixo de 0,1\u00a0mg\/mL (~0,3\u00a0UI\/mL), a prote\u00edna transportadora (BSA a 0,1% de concentra\u00e7\u00e3o final) minimiza as perdas por adsor\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is HGH 191AA used for in studies?<\/h3>\n<p>HGH 191AA is used in studies investigating direct growth hormone receptor pharmacology, JAK2\/STAT5 signalling, hepatic IGF-1 induction, anabolic signalling in muscle and bone, hepatic metabolism, sleep-GH-axis relationships, GH-deficiency preclinical models, and comparative GH-axis pharmacology against GHRH analogs and growth hormone secretagogues. It is the canonical exogenous GH tool. The pharmaceutical-grade HGH 191AA sold here is <strong>n\u00e3o<\/strong> FDA-approved for non-clinical human use and is supplied strictly for clinical studies use only. <\/p>\n<h3>Qual \u00e9 a diferen\u00e7a entre HGH 191AA e 192AA?<\/h3>\n<p>The 191AA form is the modern pharmaceutical-quality recombinant human growth hormone matching the exact native human sequence (191 amino acids). The 192AA form was an older bacterial-recombinant variant with an additional N-terminal methionine residue (192 amino acids total) that was used in early pharmaceutical development before mammalian-cell expression systems became standard. The extra methionine produced minor antigenicity in some patient populations and the 192AA form has been largely phased out of both studies and clinical use. All pharmaceutical-grade HGH from MedsBase is the 191AA native-sequence form. <\/p>\n<h3>Como \u00e9 que a HGH 191AA difere do Sermorelin?<\/h3>\n<p>A HGH 191AA \u00e9 a pr\u00f3pria hormona de crescimento ex\u00f3gena \u2014 o ligando ativo do recetor. <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> is a 29-amino-acid analog of GHRH (growth hormone releasing hormone) that stimulates the pituitary to release ENDOGENOUS GH. The downstream effects are similar in direction but qualitatively different: HGH produces tonic GHR exposure following each injection and bypasses pituitary feedback, while sermorelin produces a pulsatile GH release pattern and preserves natural somatostatin feedback regulation. Studies designs typically use one or the other depending on whether the question is about direct GHR pharmacology (HGH) or hypothalamic-pituitary-axis dynamics (sermorelin). <\/p>\n<h3>Como \u00e9 que a HGH 191AA difere do IGF-1 LR3?<\/h3>\n<p>A HGH 191AA atua no recetor de GH, que impulsiona a produ\u00e7\u00e3o de IGF-1 pelo f\u00edgado como o principal efetor subsequente. <a href=\"https:\/\/medsbase.com\/pt-pt\/igf-1-lr3\/\">IGF-1 LR3<\/a> bypasses this step and acts directly on the IGF-1 receptor. HGH studies the full GH\/IGF-1 axis including the upstream liver-mediated IGF-1 induction; IGF-1 LR3 isolates the IGF-receptor pharmacology and the direct downstream Akt\/mTOR anabolic signalling. Both compounds are frequently used in parallel arms of the same studies design to dissect direct GH effects from IGF-1-mediated effects. <\/p>\n<h3>What is the typical HGH 191AA dose?<\/h3>\n<p>Published preclinical studies dose ranges are typically 1\u20138\u00a0IU per administration in rodent and primate models, given subcutaneously once daily or pulsed to mimic endogenous secretion patterns. A 10\u00a0IU vial reconstituted with 1.0\u00a0mL bacteriostatic water yields 10\u00a0IU\/mL \u2014 0.1\u00a0mL equals 1\u00a0IU, 0.2\u00a0mL equals 2\u00a0IU. The conversion factor is approximately 3\u00a0IU per mg of recombinant 191AA HGH (WHO international standard). <\/p>\n<h3>O HGH 191AA \u00e9 aprovado pela FDA?<\/h3>\n<p>Pharmaceutical recombinant 191AA HGH (somatropin) is FDA-approved under multiple brand names (Genotropin, Humatrope, Norditropin, Saizen, Omnitrope, Nutropin and others) for specific medical indications including paediatric growth hormone deficiency, adult GH deficiency, Turner syndrome, idiopathic short stature, AIDS-associated wasting, and short bowel syndrome \u2014 only under prescription and supervision by an endocrinologist. It is the most stringently regulated of all peptides in many jurisdictions. <\/p>\n<h3>Como deve ser armazenado o HGH 191AA?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para stock de trabalho a curto prazo, ou \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, utilizar no prazo de 14 dias (menos tempo do que os p\u00e9ptidos pequenos t\u00edpicos, porque a estrutura de quatro h\u00e9lices \u00e9 mais suscet\u00edvel \u00e0 adsor\u00e7\u00e3o superficial e desamida\u00e7\u00e3o lenta). N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o produzem agrega\u00e7\u00e3o e perda de atividade. Proteger sempre da luz direta. <\/p>\n<h3>Como reconstituir o HGH 191AA?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o liofilizado), agite suavemente e aguarde 5 a 10 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agitar suavemente o frasco \u2014 agita\u00e7\u00e3o vigorosa pode perturbar a estrutura de quatro h\u00e9lices e reduzir a atividade biol\u00f3gica. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 l\u00edmpida e incolor, sem part\u00edculas vis\u00edveis. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>MedsBase carries HGH 191AA in 10\u00a0IU, 15\u00a0IU, 24\u00a0IU, 36\u00a0IU, and 40\u00a0IU lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at \u226598% HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Por que \u00e9 o HGH medido em UI em vez de mg?<\/h3>\n<p>International Units (IU) are the standard measurement for biological-activity-based labelling of protein hormones, established by the WHO International Standard. For recombinant 191AA HGH, the conversion factor is approximately 3\u00a0IU per mg. The IU labelling convention is preferred because it directly references biological potency rather than mass, which is more reproducible across different recombinant production batches that may vary slightly in glycosylation state, deamidation profile, and folding-state heterogeneity. Both IU and mg are valid; the IU is the dominant unit in clinical and literature. <\/p>\n<h3>Por que \u00e9 a especifica\u00e7\u00e3o de pureza de 98% em vez de 99%?<\/h3>\n<p>Recombinant proteins like HGH cannot always achieve the \u226599% HPLC purity standard typical of small synthetic peptides because of inherent heterogeneity in any recombinant expression system \u2014 minor variants in folding state, deamidation isoforms, and other related species appear as related peaks on HPLC that are not impurities but isoforms of the target protein. \u226598% HPLC purity is a strong pharmaceutical-grade specification for recombinant 191AA HGH, intermediate between the 95% common for larger glycoproteins like <a href=\"https:\/\/medsbase.com\/pt-pt\/follistatin-344\/\">Follistatina 344<\/a> e os 99% comuns para p\u00e9ptidos sint\u00e9ticos pequenos. <\/p>\n<h3>Does HGH 191AA cause side reported effects?<\/h3>\n<p>The principal on-target effects of HGH in study models are anabolic and metabolic: increased IGF-1 levels, increased lean body mass, decreased adiposity, transient insulin resistance, sodium and water retention, and increased mitogenic signalling. At supraphysiological exposures, off-target effects include carpal tunnel symptoms in primate models, glucose dysregulation, and (with chronic exposure) joint and soft-tissue overgrowth. The very strict regulatory framework around HGH for human use reflects these on-target risks at non-physiological doses. <\/p>\n<h3>Qual \u00e9 a meia-vida da HGH 191AA?<\/h3>\n<p>In preclinical studies, recombinant HGH has a plasma half-life of approximately 3\u20135 hours following subcutaneous administration. The relatively short half-life reflects renal filtration (a 22-kDa protein is at the boundary of the glomerular filtration cutoff) and proteolytic clearance. Tissue half-life is longer because GHR-bound HGH persists at the cell surface for some time before internalisation. For protocols requiring sustained exposure, repeated daily dosing or specialised long-acting formulations would be needed; the standard recombinant 191AA form does not provide multi-day exposure from a single injection. <\/p>\n<h3>How long does HGH 191AA take to show effects in preclinical studies?<\/h3>\n<p>Os efeitos agudos na fosforila\u00e7\u00e3o de JAK2\/STAT5 e no programa de transcri\u00e7\u00e3o imediata responsivo \u00e0 GH s\u00e3o detet\u00e1veis dentro de horas ap\u00f3s a administra\u00e7\u00e3o. A indu\u00e7\u00e3o hep\u00e1tica de IGF-1 atinge o pico dentro de 24 horas. Os efeitos na composi\u00e7\u00e3o corporal (massa magra, massa adiposa) tornam-se tipicamente estatisticamente significativos ap\u00f3s 2\u20134 semanas de dosagem regular em modelos de roedores e continuam a acumular-se ao longo de 8\u201312 semanas de administra\u00e7\u00e3o cont\u00ednua. <\/p>\n<h3>Posso encomendar HGH 191AA para envio internacional?<\/h3>\n<p>Sim, onde as regulamenta\u00e7\u00f5es locais permitem. A MedsBase envia HGH 191AA para todo o mundo a partir da nossa rede dedicada de envio de pept\u00eddeos. Encomendas apenas de pept\u00eddeos qualificam-se para o nosso servi\u00e7o de envio de pept\u00eddeos independente. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura com rastreio completo e est\u00e3o cobertas pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Garantia de Reenvio<\/a>. Note that HGH is the most stringently regulated peptide in many jurisdictions \u2014 please verify that local laws permit acquisition in your destination country before ordering. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Growth-Axis, GH-Release, and Anabolic Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 An\u00e1logo de GHRH(1-29) \u2014 estimula a liberta\u00e7\u00e3o end\u00f3gena de GH<\/li>\n<li><a href=\"\/pt-pt\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 Long-acting GHRH analog \u2014 canonical long-half-life GHRH use<\/li>\n<li><a href=\"\/pt-pt\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Secretagogo de hormona de crescimento seletivo \u2014 pulso de GH limpo sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-pt\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 An\u00e1logo recombinante de IGF-1 com longa arginina \u2014 contorna o passo da GH<\/li>\n<li><a href=\"\/pt-pt\/ghrp-6\/\"><strong>GHRP-6<\/strong><\/a> \u2014 First-generation hexapeptide GHS \u2014 ghrelin-axis GH release studies<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore o eixo da hormona de crescimento<\/strong><\/p>\n<p style=\"margin: 0;\">Explore a gama completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, com compostos relacionados do eixo GH incluindo <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> for endogenous-pulse studies, <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> for selective GHS studies, and <a href=\"https:\/\/medsbase.com\/pt-pt\/igf-1-lr3\/\">IGF-1 LR3<\/a> para o bra\u00e7o descendente do eixo IGF.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Hormona de crescimento humana recombinante 191-aa (somatropina)<br \/>\n\u2705 Sequ\u00eancia humana nativa \u2014 forma farmac\u00eautica moderna de qualidade<br \/>\n\u2705 Agonista direto do recetor de GH (~22 kDa)<br \/>\n\u2705 Convers\u00e3o padr\u00e3o de ~3 UI por mg<br \/>\n\u2705 Pureza \u226598% em HPLC, COA dispon\u00edvel mediante pedido<\/p>\n<p><strong>HGH 191AA<\/strong> \u00e9 uma prote\u00edna recombinante.<\/p>","protected":false},"featured_media":70958,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6288,5441],"class_list":["post-70770","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-hgh","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/70770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=70770"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70958"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=70770"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=70770"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=70770"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=70770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}